We are live on ! Find out more
HGEN

HUMANIGEN, INC.

Delisted

HGEN was delisted on the 25th of July, 2023.

65 hedge funds and large institutions have $38.8M invested in HUMANIGEN, INC. in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 23 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more call options, than puts

Call options by funds: $1.79M | Put options by funds: $1.65M

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

22% less funds holding

Funds holding: 8365 (-18)

43% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 23

50% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 30

55% less capital invested

Capital invested by funds: $86M → $38.8M (-$47.2M)

Holders
65
Holders Change
-18
Holders Change %
-21.69%
% of All Funds
1.09%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
13
Reduced
23
Closed
30
Calls
$1.79M
Puts
$1.65M
Net Calls
+$140K
Net Calls Change
-$1.8M
Name Holding Trade Value Shares
Change
Change in
Stake
VCM
1
Valiant Capital Management
California
$12.2M
M
2
Murchinson
Ontario, Canada
$9.29M
Vanguard Group
3
Vanguard Group
Pennsylvania
$4.34M +$57.9K +25,799 +1%
CAC
4
Cowen and Company
New York
$2M +$849K +378,174 +50%
BlackRock
5
BlackRock
New York
$1.68M -$5.43M -2,417,421 -72%
Marshall Wace
6
Marshall Wace
United Kingdom
$1.08M -$1.4M -624,232 -51%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$914K -$616K -274,613 -35%
Millennium Management
8
Millennium Management
New York
$822K +$1.04M +464,355 New
Morgan Stanley
9
Morgan Stanley
New York
$779K +$177K +79,005 +22%
State Street
10
State Street
Massachusetts
$676K -$1.94M -865,246 -69%
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$624K -$661K -294,438 -45%
Charles Schwab
12
Charles Schwab
California
$466K -$149K -66,275 -20%
E
13
Ergoteles
New York
$425K +$539K +239,900 New
GCP
14
GSA Capital Partners
United Kingdom
$413K +$237K +105,438 +82%
Goldman Sachs
15
Goldman Sachs
New York
$382K +$258K +114,858 +114%
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
$298K -$1.16M -516,136 -75%
Fidelity Investments
17
Fidelity Investments
Massachusetts
$215K -$19.7K -8,772 -7%
XT
18
XTX Topco
Cayman Islands
$207K +$180K +79,972 +217%
Bank of America
19
Bank of America
North Carolina
$202K -$480K -213,939 -65%
OQS
20
Occudo Quantitative Strategies
Florida
$201K -$10.5K -4,656 -4%
Citadel Advisors
21
Citadel Advisors
Florida
$185K -$201K -89,374 -46%
SSA
22
Schonfeld Strategic Advisors
New York
$151K -$27.6K -12,300 -13%
Northern Trust
23
Northern Trust
Illinois
$148K -$809K -360,510 -81%
TI
24
Telemetry Investments
New York
$129K +$14.6K +6,500 +10%
FWM
25
Frontier Wealth Management
Missouri
$108K

HGEN Hedge Fund Activity: Q2 2022 in Review

65 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in HUMANIGEN, INC. (HGEN) for Q2 2022, worth a combined $38.8M — down 55% from $86M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of HGEN and 15 opened new positions — a net loss of 15 holders — while 23 trimmed existing stakes and 13 added.

The largest buyer was Millennium Management, opening a new position worth an estimated $1.04M. The largest seller was BlackRock, cutting an estimated $5.43M.

  • 65 institutional investors held HUMANIGEN, INC. (HGEN) as of Q2 2022, down from 83 in Q1 2022.
  • Funds reported $38.8M of HUMANIGEN, INC. stock for Q2 2022, down 55% quarter-over-quarter.
  • 15 funds opened new HUMANIGEN, INC. positions in Q2 2022 and 30 closed out, a net change of -15 holders.
  • The largest HUMANIGEN, INC. buyer in Q2 2022 was Millennium Management, an estimated $1.04M added.
  • The largest HUMANIGEN, INC. seller in Q2 2022 was BlackRock, an estimated $5.43M sold.

Based on aggregated 13F filings for Q2 2022.